PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study

Immunotherapy with check-point inhibitors serves as a promising treatment strategy in patients with upper gastrointestinal (GI) tumors. Human epidermal growth factor receptor 2 (HER2) is the only identified therapeutic target in upper GI tumors, whose potential interaction with programmed death-liga...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, Andrea, Taghizadeh, Hossein, Schiefer, Ana-Iris, Puhr, Hannah C., Karner, Alexander K., Jomrich, Gerd, Schoppmann, Sebastian F., Kain, Renate, Preusser, Matthias, Ilhan-Mutlu, Aysegül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471145/
https://www.ncbi.nlm.nih.gov/pubmed/32372174
http://dx.doi.org/10.1007/s12253-020-00814-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471145/
https://www.ncbi.nlm.nih.gov/pubmed/32372174
http://dx.doi.org/10.1007/s12253-020-00814-2

Ejemplares similares